PPT-Biodiversity and Availability of Medicines

By Ismaeel Umar Yunus BPharm RPh African League Of Young Masters ALYM Weekly meeting 16th March 2013 Outline T he meaning of Biodiversity The scope of Biodiversity The benefits of Biodiversity. The complexity and rich diversity of life found in forests provides many vital services to human beings Nonetheless humans are destroying forest biodiversity at an alarming rate The conversion of forests to agricultural land overgrazing unsustainabl Agricultural biodiversity includes ecosystems animals plants and microorganisms related to food and agriculture Today most species of crops and domesticated livestock are the result of thousands of years of human intervention such as selective breed A Study of Two Diverse Government Drug Procurement. and Distribution Systems in India. Sakthivel. . Selvaraj. , . Habib. . Hasan. Public Health Foundation of India, India. 1. Background. Provision of safe and effective medicines to patients is one of the central goals of a public health system. . Presented by . Deirdre Dimancesco. Department of Essential Medicines and . H. ealth Products, WHO. at the . Technical Briefing Seminar. 15 April, 2013 . MeTA. aim. MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and policy dialogue among stakeholders.. Biodiversity, ecosystem services and human wellbeing . Outline of Lecture. From empty world to full world. Biodiversity, ecosystem goods and ecosystem services. Biodiversity, markets and the nature of resources. It is the variety of all the different living things and their homes on the planet. . BIO. . DIVERSITY. Bio= biological organisms . -living things!. diversity= the amount of variation. WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). Presented by . Deirdre Dimancesco. Department of Essential Medicines and . H. ealth Products, WHO. at the . Technical Briefing Seminar. 15 April, 2013 . MeTA. aim. MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and policy dialogue among stakeholders.. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . Match the following to the correct description. One Teacher. species. population. community. ecosyste. m. All Teachers. Teachers and Students. George West. Look through the vocabulary cards on your desk.. André Mader. Institute for Global Environmental Strategies (IGES). Institutional structure of the CBD. Executive Secretary. Programme Officers. General service staff. Interns. Contractors. Associate Programme Officers. UPDATE ON PROCESS AND UPDATED ZERO DRAFT . OEWG Co-Chairs. Francis Ogwal. Basile van Havre. 18 SEPTEMBER 2020 . Special Briefing Session. Presentation Plan. Process. Planning assumptions. Roles of subsidiary bodies and working group. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...